Learning objectives
After watching the webinar, participants will be able to:
Needs assessment
To teach healthcare professionals how to make better use of injectable medicines to manage risk factors for cardiovascular events, such as dyslipidaemia and diabetes, based on study findings that have identified facilitators and barriers of these novel agents with CV benefits.
This programme is supported by Amgen and Novo Nordisk in the form of an educational grant. The scientific programme has not been influenced in any way by its sponsors.
Main Topic
Session information
This webinar is designed for cardiologists, nurses and allied professionals, and those wishing to update their scientific knowledge on the topic.
During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.
Technical settings
The webinar is available on PC and tablets. The use of a smartphone is not recommended.
To answer the MCQs during the live, you must allow pop-up windows.
A high-speed Internet connection is required (minimum 2 Mbps).